RIGLRigel Pharmaceuticals, Inc.

RIGL Stock Price, Valuation & Chart | Rigel Pharmaceuticals, Inc.

Compare

$49.420+1.92 (+4.04%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology RIGL intrinsic value RIGL calculated fair value vs price

Overview Financials Dividends Ratios

RIGL Historical price chart

RIGL Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization914.37M

PE Ratio12.61

EPS3.92

Trading Volume184.66K

Today's High/Low49.65/47.73

Dividend Yield0.00

52 Week High/Low52.24/24.95

Shares Outstanding18.50M

RIGL Financial Statement

RIGL Analyst ratings

RIGL Analysis & performance metrics

RIGL Company profile

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The…

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the…

RIGL Management team

Name

Position

Joseph Lasaga

Executive Vice President & Chief Business Officer

Raymond J. Furey J.D.

Executive Vice President, Chief Compliance Officer, General Counsel & Corporate Secretary

Tarek Sallam

Vice President of Marketing

Dean L. Schorno CPACFO

Executive Vice President & Chief Financial Officer

David A. Santos

Executive Vice President & Chief Commercial Officer

Raul R. RodriguezCEO

President, Chief Executive Officer & Director

Lisa Rojkjaer M.D.

Executive Vice President & Chief Medical Officer

Julie Patel

Senior Vice President of Human Resources

Name

Position

Joseph Lasaga

Executive Vice President & Chief Business Officer

Raymond J. Furey J.D.

Executive Vice President, Chief Compliance Officer, General Counsel & Corporate Secretary

Tarek Sallam

Vice President of Marketing

Dean L. Schorno CPACFO

Executive Vice President & Chief Financial Officer

David A. Santos

Executive Vice President & Chief Commercial Officer

Raul R. RodriguezCEO

President, Chief Executive Officer & Director

Lisa Rojkjaer M.D.

Executive Vice President & Chief Medical Officer

Julie Patel

Senior Vice President of Human Resources

Management Team

Joseph Lasaga

Executive Vice President & Chief Business Officer

Raymond J. Furey J.D.

Executive Vice President, Chief Compliance Officer, General Counsel & Corporate Secretary

Tarek Sallam

Vice President of Marketing

Dean L. Schorno CPACFO

Executive Vice President & Chief Financial Officer

David A. Santos

Executive Vice President & Chief Commercial Officer

Raul R. RodriguezCEO

President, Chief Executive Officer & Director

Lisa Rojkjaer M.D.

Executive Vice President & Chief Medical Officer

Julie Patel

Senior Vice President of Human Resources

Management

Joseph Lasaga

Executive Vice President & Chief Business Officer

Raymond J. Furey J.D.

Executive Vice President, Chief Compliance Officer, General Counsel & Corporate Secretary

Tarek Sallam

Vice President of Marketing

Dean L. Schorno CPACFO

Executive Vice President & Chief Financial Officer

David A. Santos

Executive Vice President & Chief Commercial Officer

Raul R. RodriguezCEO

President, Chief Executive Officer & Director

Lisa Rojkjaer M.D.

Executive Vice President & Chief Medical Officer

Julie Patel

Senior Vice President of Human Resources

Total 8 executives

RIGL Frequently asked questions

What is Rigel Pharmaceuticals, Inc. (RIGL) Stock Price?

Current stock price of Rigel Pharmaceuticals, Inc. (RIGL) stock is $49.420. The stock price is +4.04% higher in the session. The intraday range can be seen from this page. Volume of Rigel Pharmaceuticals, Inc. (RIGL) stock is 184.66K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Rigel Pharmaceuticals, Inc. (RIGL) stock price going up or down today?

The stock price of Rigel Pharmaceuticals, Inc. (RIGL) can change with earnings, company news, and overall market sentiment. Rigel Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Rigel Pharmaceuticals, Inc. stock expensive at its current price?

Whether Rigel Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RIGL on this page is 12.61. EPS on this page is 3.92. Compare those figures with peers and growth expectations before deciding if the current Rigel Pharmaceuticals, Inc. price is justified.

How has the stock price of Rigel Pharmaceuticals, Inc. (RIGL) performed historically?

Historical performance for Rigel Pharmaceuticals, Inc. (RIGL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RIGL reacted to past earnings and market events.

Should I buy Rigel Pharmaceuticals, Inc. (RIGL) stock, at this price?

Buying Rigel Pharmaceuticals, Inc. (RIGL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.